There are currently 202 clinical trials in Oakland, California looking for participants to engage in research studies. Trials are conducted at various facilities, including Kaiser Permanente-Oakland, CCOP - Bay Area Tumor Institute, UCSF Benioff Children's Hospital Oakland and Alta Bates Summit Medical Center - Summit Campus. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Collaborative Approach to Examining Adversity and Building Resilience Study
NCT05259436
Recruiting
To examine the behavioral, psychosocial, and biologic impact of resilience-promoting interventions associated with primary care.
Gender:
All
Ages:
2 years and above
Trial Updated:
07/17/2023
Locations: UCSF Benioff Children's Hospital Oakland, Oakland, California
Conditions: Early Life Adversity, Caregiver Stress
Register for Updates
Prepare for Your Diabetes Care
NCT05263310
Recruiting
As adults with type 2 diabetes age, they are increasingly vulnerable to treatment-related hypoglycemia and its related complications (including hospitalization and death). This study proposes to evaluate, in a randomized clinical trial, a strategy of expanded advance care planning to support older adults in value-aligned re-assessment of diabetes treatment regimens with their primary care team. If the aims of this project are achieved and incidence of clinically-significant hypoglycemia is reduc... Read More
Gender:
All
Ages:
75 years and above
Trial Updated:
07/14/2023
Locations: Kaiser Permanente - Oakland Medical Center, Oakland, California
Conditions: Type 2 Diabetes Mellitus With Hypoglycemia, Aging, Patient Activation
Register for Updates
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
NCT03937635
Recruiting
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/21/2023
Locations: Alta Bates Summit Medical Center - Summit Campus, Oakland, California +1 locations
Conditions: Smoldering Plasma Cell Myeloma
Register for Updates
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992
Recruiting
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-sma... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/20/2023
Locations: Alta Bates Summit Medical Center - Summit Campus, Oakland, California +4 locations
Conditions: ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Register for Updates
The Resilience Clinic Evaluation
NCT05690256
Recruiting
Early life adversity can affect children's physical and mental health. The Resilience Clinic is a support program for young children and their caregivers who have been exposed to significant adversity, aiming to prevent the harmful effects of stress and improve child health, behavior, and development while also reducing caregiver stress. This study seeks to evaluate the Resilience Clinic, assessing the intervention's impact on child health, behavior, and development and caregiver stress and ment... Read More
Gender:
All
Ages:
Between 2 years and 5 years
Trial Updated:
05/26/2023
Locations: La Clinica de la Raza, Oakland, California +2 locations
Conditions: Early Life Adversity, Caregiver Stress
Register for Updates
Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer
NCT05805657
Recruiting
The train-the-trainer (TTT) approach is a promising method of sustaining training efforts in community mental health centers (CMHCs). This study will test the implementation and effectiveness outcomes of a sleep treatment delivered by CMHC providers who are trained and supervised within CMHCs via TTT. The investigators will test two versions of the sleep treatment, a "Standard" version and an "Adapted" version that has been adapted using theory, data and stakeholder inputs to improve the fit for... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/11/2023
Locations: Alameda County Behavioral Health Care Services, Oakland, California
Conditions: Sleep Disorder, Circadian Dysregulation
Register for Updates
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
NCT05773144
Recruiting
To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/05/2023
Locations: Kaiser Permanente Northern California, Oakland, California
Conditions: Colonic Neoplasms
Register for Updates
Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
NCT05754008
Recruiting
The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA [Active Outreach to Younger Latinx]) within Kaiser Permanente Northern California (KPNC).
Gender:
All
Ages:
Between 21 years and 44 years
Trial Updated:
04/25/2023
Locations: Kaiser Permanente Northern California, Oakland, California
Conditions: Diabetes Mellitus, Type 2
Register for Updates
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
NCT05268094
Recruiting
COMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by single vs. two ventricle status. Participants will be followed through the first year of life.
Gender:
All
Ages:
Between 1 day and 30 days
Trial Updated:
04/12/2023
Locations: UCSF Benioff Children's Hospitals, Oakland, California
Conditions: Congenital Heart Disease in Children
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Gender:
All
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: UCSF Benioff Children's Hospital of Oakland, Oakland, California
Conditions: Langerhans Cell Histiocytosis
Register for Updates
Alcohol Telemedicine Consultation in Primary Care (ATC)
NCT05252221
Recruiting
This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol use problems and alcohol use disorder (AUD) pharmacotherapy and specialty addiction treatment entry.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/07/2023
Locations: Kaiser Permanente, Oakland, California
Conditions: Alcohol Use Disorder (AUD), Pharmacist-Patient Relations, Alcohol Problem
Register for Updates
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
NCT05267821
Recruiting
The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).
Gender:
All
Ages:
Between 1 day and 17 years
Trial Updated:
02/07/2023
Locations: Benioff Children's Hospital - Oakland, Oakland, California
Conditions: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Register for Updates